pizotyline has been researched along with Esophageal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Dong, Z; Duan, L; Gu, H; Guo, Y; He, X; Jiang, Y; Li, M; Liu, K; Yu, Y; Zhao, J; Zhao, X; Zhou, H; Zhou, Y | 1 |
1 other study(ies) available for pizotyline and Esophageal Neoplasms
| Article | Year |
|---|---|
Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Malates; NF-E2-Related Factor 2; Pizotyline | 2023 |